Skip to main content
Empaveli 1080 mg/20mL injection, solution by Apellis Pharmaceuticals, Inc.
Empaveli, 1080 mg/20mL, injection, solution Drug class: Complement Inhibitor. Available on prescription only. Listed by Apellis Pharmaceuticals, Inc..
Prescription only

Empaveli

Pegcetacoplan

Listed by Apellis Pharmaceuticals, Inc.

Strength
1080 mg/20mL
Form
Injection, Solution
Route
Subcutaneous
Class
Complement Inhibitor

What it contains

  • Pegcetacoplan 1080 mg/20mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Complement Inhibitor
Approval route NDA — original brand approval
NDC code 73606-010
FDA application NDA215014
RxNorm concept 2557386
Package sizes listed 1
Marketed since May 2021

Other products containing Pegcetacoplan

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Syfovre

Pegcetacoplan

Strength
15 mg/.1mL
Form
Injection, Solution
Class
Complement Inhibitor
Rx only

Apellis Pharmaceuticals, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.